The Clinical Study of Omics with Plasma and Urine in Chronic Heart Failure Patients: The Investigation with Peripheral Blood

Not Applicable

• Conditions: Cardiovascular disease

• Registration Number: JPRN-UMIN000036328
• Lead Sponsor: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-01
• Study Completion: 2020-08-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 759

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who were judged to be not eligible in the present study by the physician in charge.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Genetic rare variant, single nucleotide polymorphism, metabolite, protein, and micro RNA.

Secondary Outcome Measures

Name	Time	Method
Clinical information (sex, age, height, body weight, blood pressure, heart rate, SAS, NYHA class, HF stage class, heart disease, echocardiogram, blood test, urine test, chest X-ray, electrocardiogram, drug allergy, past history, smoking, drinking, family history).